Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366963 · ClinicalTrials.gov registry record
Cognitive Dysfunction in Postural Tachycardia Syndrome
A clinical trial of Postural Tachycardia Syndrome, sponsored by Vanderbilt University.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT01366963: Completed study of Postural Tachycardia Syndrome, sponsored by Vanderbilt University.
NCT01366963 is a study of Postural Tachycardia Syndrome that has completed, run by Vanderbilt University. The registered enrollment target is 60 participants, below the 79-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01366963, a study of Postural Tachycardia Syndrome, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
A common complaint among people with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This is very poorly understood. To better understand this cognitive dysfunction, the investigators will test people with POTS and people without POTS using various neuropsychiatric instruments. The investigators hypothesis is that people with POTS will have greater abnormalities on neuropsychiatric testing than normal controls.
Primary Outcome
This is a continuous variable that will provide a measure of attention with orthostatic stress.
Conditions Studied
Interventions
- BEHAVIORAL Seated Measurements
- BEHAVIORAL Standing Measurements
- BEHAVIORAL Self-Administered Surveys
Study Locations (1)
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-03 |
| Est. Completion | 2015-06 |
What the finished NCT01366963 record still lists
NCT01366963 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 79-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Seated Measurements is the first listed.
NCT01366963 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01366963 about?
NCT01366963 is a clinical study titled "Cognitive Dysfunction in Postural Tachycardia Syndrome". A common complaint among people with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This is very poorly understood. To better understand this cognitive dysfunction, the investigators will test people with POTS and people without POTS using various neuropsychiatric i...
What is the current status of trial NCT01366963?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2011-03. Estimated completion is 2015-06.
What conditions does trial NCT01366963 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome.
What interventions are being tested in trial NCT01366963?
The interventions under investigation include: Seated Measurements (BEHAVIORAL), Standing Measurements (BEHAVIORAL), Self-Administered Surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT01366963?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01366963 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01366963's enrollment target sits among peer trials
60 7th of 19 higher than 13 of 19 other Postural Tachycardia Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postural Tachycardia Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
RECRUITING · NA
-
Inappropriate Sinus Tachycardia Registry
RECRUITING
-
Autoimmune Basis for Postural Tachycardia Syndrome
RECRUITING · NA
-
A Study of Pyridostigmine in Postural Tachycardia Syndrome
RECRUITING · Phase 2
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia